BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+9.6%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$10.2B
AUM Growth
+$793M
(+8.4%)
Cap. Flow
+$196M
Cap. Flow
% of AUM
1.92%
Top 10 Holdings %
Top 10 Hldgs %
30.33%
Holding
228
New
12
Increased
77
Reduced
41
Closed
15
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$72M |
| 2 |
Tandem Diabetes Care
TNDM
|
$48M |
| 3 |
IQVIA
IQV
|
$42.6M |
| 4 |
Adaptive Biotechnologies
ADPT
|
$39.3M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$39M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$238M |
| 2 |
Moderna
MRNA
|
$62.9M |
| 3 |
Cigna
CI
|
$45.4M |
| 4 |
Bristol-Myers Squibb
BMY
|
$41.5M |
| 5 |
DaVita
DVA
|
$39.6M |
Sector Composition
| 1 | Healthcare | 96.41% |
| 2 | Industrials | 0.94% |
| 3 | Technology | 0.31% |
| 4 | Financials | 0.04% |
| 5 | Consumer Discretionary | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Transmedics
TMDX
$3.51B
| $24.2M | 0.24% |
729,989
-12,211
| -2% | -$405K |
|
102
Axsome Therapeutics
AXSM
$6.18B
| $23.7M | 0.23% |
+352,021
| New | +$23.7M |
|
103
Privia Health
PRVA
$2.83B
| $23.3M | 0.23% |
+525,000
| New | +$23.3M |
|
104
Outset Medical
OM
$236M
| $22.8M | 0.22% |
30,471
+13,423
| +79% | +$10.1M |
|
105
ResMed
RMD
$40B
| $21.7M | 0.21% |
88,145
| – | – |
|
106
Zai Lab
ZLAB
$3.34B
| $21.6M | 0.21% |
122,000
+35,500
| +41% | +$6.28M |
|
107
Thermo Fisher Scientific
TMO
$184B
| $21.2M | 0.21% |
41,974
+5,400
| +15% | +$2.72M |
|
108
Inogen
INGN
$223M
| $18.3M | 0.18% |
280,863
| – | – |
|
109
Avantor
AVTR
$8.92B
| $18.2M | 0.18% |
512,216
| – | – |
|
110
Wave Life Sciences
WVE
$1.27B
| $17.3M | 0.17% |
2,602,858
| – | – |
|
|
EAR
111
DELISTED
Eargo, Inc. Common Stock
EAR
| $17.3M | 0.17% |
21,703
+2,310
| +12% | +$1.84M |
|
|
CELL
112
DELISTED
PhenomeX Inc. Common Stock
CELL
| $17.3M | 0.17% |
385,014
+6,011
| +2% | +$269K |
|
113
Legend Biotech
LEGN
$6.42B
| $16M | 0.16% |
390,163
-213,080
| -35% | -$8.75M |
|
|
IMAB
114
I-MAB
IMAB
$348M
| $15.4M | 0.15% |
183,457
-15,000
| -8% | -$1.26M |
|
115
Oscar Health
OSCR
$4.77B
| $14.9M | 0.15% |
694,136
+239,562
| +53% | +$5.15M |
|
|
AMED
116
DELISTED
Amedisys
AMED
| $14.8M | 0.14% |
60,487
| – | – |
|
|
GTH
117
DELISTED
Genetron Holdings Limited ADS
GTH
| $14.6M | 0.14% |
241,046
+30,350
| +14% | +$1.83M |
|
|
BNR
118
Burning Rock Biotech
BNR
$91.2M
| $14.4M | 0.14% |
48,989
+5,696
| +13% | +$1.68M |
|
119
CareDx
CDNA
$687M
| $13.6M | 0.13% |
148,871
-41,500
| -22% | -$3.8M |
|
120
CVS Health
CVS
$93.2B
| $13.4M | 0.13% |
160,148
+35,600
| +29% | +$2.97M |
|
121
Q32 Bio
QTTB
$20.1M
| $12.6M | 0.12% |
96,507
| – | – |
|
122
Neuropace
NPCE
$321M
| $12.1M | 0.12% |
+507,930
| New | +$12.1M |
|
|
XENT
123
DELISTED
Intersect ENT, Inc
XENT
| $10.6M | 0.1% |
617,968
| – | – |
|
124
Dentsply Sirona
XRAY
$2.84B
| $10.1M | 0.1% |
159,129
| – | – |
|
125
Labcorp
LH
$22.8B
| $9.99M | 0.1% |
42,137
+25,608
| +155% | +$6.07M |
|